Long-term outcomes of alemtuzumab in relapsing–remitting multiple sclerosis: a real-world cohort with particular focus on treatment sequencing after natalizumab

Journal of the Neurological Sciences · Elsevier

Аннотация

Publication date: 15 December 2026 Source: Journal of the Neurological Sciences, Volume 491 Author(s): Marta Gaggiola, Valentina Annamaria Mauceri, Giovanni Zanotelli, Marco Zoccarato, Paolo Gallo, Francesca Rinaldi, Paola Perini, Marco Puthenparampil

Читать у издателя →

Похожие статьи